PSYCHOLOGICAL CHARACTERISTICS OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
Abstract
Introduction. In recent years, along with traditional risk factors, active attention has been paid to the psychological state of patients. Objective. To evaluate the psychological status and its influence on the quality of life in patients with non-ST-segment elevation acute coronary syndrome (NSTE-A CS). Materials and methods. The study included 131 patients with NSTE-A CS. Psychological status was evaluated using Beck’s Depression Inventory, integrative anxiety test and SF-36 quality of life questionnaire. The follow-up period was 6 months. Results. Half of the patients (53 %, n = 69) showed signs of depression, from them 66 % (n = 46) had mild depression, 16 % (n = 11) had moderate depression, 17 % (n = 12) had severe depression. High level of personal anxiety had 33 (25 %) patients, high level of situational anxiety — 20 (15 %) patients. Asthenic component, phobic component and anxious evaluation of perspective prevailed in both personal and situational anxiety. The emotional discomfort, assessment of perspective and phobic component were more frequent in personal anxiety. During 6 months of follow-up we registered 18 adverse outcomes (including recurrent myocardial infarction, unstable angina, stroke). In patients with high level of personal anxiety adverse outcomes were observed in 27 % of cases (n = 9), which is statistically significantly more frequent than in patients with low personal anxiety (9 %), p = 0.008. In addition, high levels of anxiety and depression were associated with lower quality of life. Conclusions. High level of anxiety in patients with NSTE-ACS is associated with lower quality of life. High personal anxiety is also associated with the risk of adverse cardiovascular outcomes, which indicates the importance of assessment and correction of psychological status.
References
Annette Holdgaard et al. Cognitive-behavioural therapy reduces psychological distress in younger patients with cardiac disease: a randomized trial, European Heart Journal. 2023; 44(11): 986–96. https://doi.org/10.1093/eurheartj/ehac792.
Henein M.Y., Vancheri S., Longo G., Vancheri F. The Impact of Mental Stress on Cardiovascular Health. Part II. J. Clin. Med. 2022; 11: 4405. https://doi.org/10.3390/jcm11154405.
Jean-Philippe Collet, Jean-Philippe Collet, Holger Thiele, Emanuele Barbato et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. European Heart Journal. 2021; 42(14): 1289–1367. https://doi.org/10.1093/eurheartj/ehaa575.
Kim J.-M., Stewart R., Lee Y.-S. et al. Effect of Escitalopram vs. Placebo Treatment for Depression on Long-Term Cardiac Outcomes in Patients with Acute Coronary Syndrome: A Randomized Clinical Trial. JAMA. 2018; 320: 350–7.
Li J., Ji F., Song J. et al. Anxiety and clinical outcomes of patients with acute coronary syndrome: a meta-analysis. BMJ Open. 2020; 10: e034135. DOI: 10.1136/ bmjopen-2019-034135.
Pogosova N., Kotseva K., De Bacquer D. et al. EUROASPIRE Investigators. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Eur J Prev Cardiol. 2017; 24(13): 1371–80. DOI: 10.1177/2047487317711334.
Taylor W.D., Aizenstein H.J., Alexopoulos G.S. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013; 18: 963–74.
Vaccarino V. et al. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J. 2020; 41(17): 1687–96. DOI: 10.1093/eurheartj/ehy913.
Xueqin Song et al. Depression predicts the risk of adverse events after percutaneous coronary intervention: A meta-analysis, Journal of Affective Disorders. 2020; 266: 158–64. https://doi.org/10.1016/j.jad.2020.01.136.
Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018; (6): 7–122. https://doi.org/10.15829/1560-4071-2018-6-7-122.
Оганов Р.Г., Погосова Г.В., Шальнова С.А., Деев А.Д. Депрессивные расстройства в общемедицинской практике по данным исследования КОМПАС: взгляд кардиолога. Кардиология. 2005; 8: 38–44.
Погосова Н.В., Бойцов С.А., Оганов Р.Г. и др. от имени исследователей 30 российских центров. Клинико-эпидемиологическая программа изучения психосоциальных факторов риска в кардиологической практике у больных артериальной гипертонией и ишемической болезнью сердца (КОМЕТА): первые результаты российского многоцентрового исследования. Кардиология. 2018; 58(9): 47–58.
Погосова Н.В., Соколова О.Ю., Юферева Ю.М. и др. от имени исследователей 30 российских центров. Психосоциальные факторы риска у пациентов с наиболее распространенными сердечно-сосудистыми заболеваниями — артериальной гипертонией и ишемической болезнью сердца (по данным российского многоцентрового исследования КОМЕТА. Кардиология. 2019; 59(8): 54–63.
Рекомендации ESC по профилактике сердечно-сосудистых заболеваний в клинической практике. Российский кардиологический журнал. 2022; 27(7): 51–5. DOI: 10.15829/1560-4071-2022-5155.
Чазов Е.И. и др. Клинико-эпидемиологическая программа изучения депрессии в кардиологической практике: у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): результаты многоцентрового исследования. Кардиология. 2007; 3: 28–37.
